DEVANI, A. R.; PRAJAPATI, V. H. Tildrakizumab for Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Review. Canadian Dermatology Today, Toronto, Canada, v. 2, n. s03, p. 3–8, 2021. Disponível em: https://canadiandermatologytoday.com/article/view/2-s03-devani-prajapati. Acesso em: 16 jul. 2024.